Von Willebrand Factor (vWF) ELISA: Comprehensive Guide

Introduction

The plasma glycoprotein von Willebrand Factor (vWF) is a critical mediator of primary haemostasis: it links sub‐endothelial collagen and platelets, and stabilises coagulation factor VIII (FVIII) in circulation. PubMed+3pmc.ncbi.nlm.nih.gov+3ncbi.nlm.nih.gov+3 Quantitative immunoassays such as enzyme-linked immunosorbent assays (ELISAs) provide vital data in both research and diagnostic settings for vWF antigen (vWF:Ag) and activity assays. This article reviews the principle, design, validation, and analytical considerations for a vWF ELISA, with relevance for research labs and commercial product positioning.

AffiELISA® Human von Willebrand factor ELISA [ VWF]

Biological Context of vWF

vWF is synthesised by endothelial cells (Weibel-Palade bodies) and megakaryocytes/platelets, secreted into plasma as multimers of varying molecular weight. ncbi.nlm.nih.gov+2pmc.ncbi.nlm.nih.gov+2 The functional high-molecular-weight multimers are crucial for platelet adhesion and aggregation under shear stress. eClinpath+1 vWF binds FVIII, protecting it from proteolytic degradation and extending its half-life. pmc.ncbi.nlm.nih.gov+1 Pathologically, defects or reduced levels of vWF underpin von Willebrand Disease (vWD) – the most common inherited bleeding disorder. cdc.gov+1 For reference, you may consult the NIH book “Physiology, von Willebrand Factor (vWF)” at the NCBI Bookshelf. ncbi.nlm.nih.gov

Why Perform a vWF ELISA?

An ELISA for vWF antigen (vWF:Ag) allows quantitative measurement of vWF protein concentration in plasma, serum, or other biological fluids. It complements functional assays (e.g., vWF collagen‐binding assay, vWF activity) and helps in research (endothelial activation, thrombosis risk) or diagnostic evaluation of bleeding disorders. practical-haemostasis.com+2pmc.ncbi.nlm.nih.gov+2 For product marketing, emphasise parameters such as sensitivity, dynamic range, precision (intra- and inter‐assay CV), and sample matrix compatibility.

Principle of Sandwich vWF ELISA

  1. A capture antibody (monoclonal or polyclonal) specific for vWF is coated onto microtitre wells. practical-haemostasis.com+1

  2. Sample (diluted plasma or other fluid) is incubated, allowing vWF antigen to bind the immobilised antibody. helena.com+1

  3. After wash steps, a detection antibody (often HRP-conjugated) binds the captured vWF. helena.com+1

  4. Enzyme substrate (commonly TMB + H₂O₂) is added, producing a colourimetric reaction measured at ~450 nm in a spectrophotometer/plate reader. The optical density (OD) correlates with vWF concentration via comparison to a standard curve. helena.com+1

  5. Data are processed (often via four-parameter logistic (4 PL) regression) to calculate sample vWF:Ag in IU/dL or ng/mL depending on calibrator. pmc.ncbi.nlm.nih.gov

Critical Validation Variables

  • Dynamic range / Limit of detection (LOD): For example, one published rabbit plasma vWF ELISA reached ~254 pg/mL detection limit. pmc.ncbi.nlm.nih.gov

  • Precision (intra- and inter-assay CV): Typical target CV <10 % within runs, <15 % between runs. One kit example reported 1.9-9.9% intra-assay CV across vWF concentrations. helena.com

  • Sample matrix and dilution: Plasma typically citrate anticoagulated. Blood group O individuals often have ~25% lower vWF levels—must be accounted for. helena.com

  • Reagent stability and storage: e.g., microwell plates coated with anti-vWF antibody stored at 2-8°C; plasma reference stored accordingly. helena.com

  • Specificity / cross-reactivity: Confirm antibodies recognise human vWF and not other plasma glycoproteins.

  • Standardisation / calibration: Use of human plasma reference pools assigned in IU or % of normal helps harmonise results across labs. practical-haemostasis.com+1

  • Sample handling artefacts: Freeze–thaw cycles may degrade vWF or alter multimer distribution, affecting assay results. pmc.ncbi.nlm.nih.gov

  • Correlation with functional assays: vWF:Ag quantifies antigen, but does not directly reflect functional binding capacity; thus interpretation should consider activity (vWF:RCo, vWF:CB) and context. practical-haemostasis.com

Assay Design Considerations for a Commercial Kit

Because your user (Gentaur/Affigen) focuses on research products, some key commercialisation and marketing-relevant considerations include:

  • Throughput: 96-well format standard; consider 384-well adaptation for high-throughput screening.

  • Sensitivity: Define lower limit of detection/quantification (e.g., ng/mL range) and dynamic range up to upper linear limit.

  • Sample types: Validate for human plasma, serum, cell-culture supernatant (if relevant), and possibly animal plasmas (mouse, rat) if research use.

  • Automation compatibility: Plate reader wavelength (450 nm with reference 650 nm) compatibility with robotic liquid handlers. FDA device submissions for vWF ELISA include such details. accessdata.fda.gov+1

  • Kit components & QC: Coated plates, slides/strips, sample diluent, calibrator/reference plasma, conjugate antibody, substrate, stop solution, wash buffer—all described in technical sheets. helena.com

  • Data reporting: Convert raw OD to vWF concentration (IU/dL or % of normal). Provide typical reference range (e.g., 50-150 IU/dL) for healthy adult plasma. practical-haemostasis.com

  • Regulatory context: Devices for vWF measurement (e.g., REAADS von Willebrand Factor Activity Test Kit) have FDA 510(k) clearance with sandwich ELISA format. accessdata.fda.gov+1

  • Marketing keywords: vWF antigen ELISA, sandwich ELISA vWF, quantitative vWF immunoassay, endothelial biomarker vWF, vWF research assay kit.

Analytical Workflow – Step-by-Step (typical)

  1. Equilibrate reagents to room temperature.

  2. Prepare standard curve dilutions (e.g., reference plasma dilutions covering low to high vWF concentrations).

  3. Dilute test samples (e.g., human citrate plasma 1:100 or as recommended). pmc.ncbi.nlm.nih.gov

  4. Add standards, controls and diluted samples to wells (e.g., 100 µL per well).

  5. Incubate predetermined time (e.g., 1 h at room temp) to allow antigen capture.

  6. Wash wells (typically 3× or as protocol requires) to remove unbound analyte.

  7. Add detection antibody conjugated to HRP; incubate.

  8. Wash again.

  9. Add TMB/H₂O₂ substrate; incubate until colour develops.

  10. Add stop solution (e.g., 0.36 N H₂SO₄) to halt reaction. accessdata.fda.gov

  11. Read absorbance at 450 nm (with reference at 650 nm).

  12. Generate standard curve (4-PL fit) and compute sample concentrations.

  13. Validate QC criteria (e.g., control recovery, CV within limits).

  14. Report vWF:Ag in IU/dL or ng/mL and interpret relative to reference range; optionally correlating with vWF activity assays and clinical context (in research use case, endothelial activation rather than diagnosis).

Data Interpretation & Research Use

  • vWF:Ag provides quantitative protein level, but does not measure functional binding capacity — for example in vWD, antigen may be near normal but multimer distribution or binding capacity reduced. pmc.ncbi.nlm.nih.gov

  • In research settings, elevated vWF:Ag may indicate endothelial activation or vascular injury; vWF is increasingly used as an endothelial biomarker. PubMed

  • Interpretation must consider physiological and pre-analytical factors: ABO blood group (group O ~25% lower vWF), pregnancy, surgery, acute phase reactions (vWF is an acute phase protein). practical-haemostasis.com

  • For a research kit, providing normative data (from healthy donors) and expected variance helps users gauge assay performance.

Troubleshooting & Common Pitfalls

  • High background OD: insufficient washing, non-specific binding, expired substrate.

  • Poor standard curve linearity: incorrect standard preparation, pipetting errors, degraded calibrator.

  • Sample CV high: poor mixing, sample haemolysis or lipemia, freeze-thaw damage.

  • Unexpected low sample values: sample dilution error, clotting or sample degradation, wrong anticoagulant.

  • Hook effect at very high antigen loads: consider additional dilution of samples with anticipated high vWF.

  • Plate reader wavelength drift: ensure calibration and reference wavelength (650 nm) use.

Keywords & SEO Considerations

To align with SEO and indexing (especially for biotech and assay kits), include within headings and body text relevant keywords such as:

  • “vWF ELISA”

  • “von Willebrand factor antigen assay”

  • “sandwich ELISA vWF:Ag”

  • “quantitative vWF immunoassay kit”

  • “endothelial biomarker vWF assay”

  • “high-throughput vWF ELISA”

  • “vWF research assay human plasma”

  • “vWF antigen measurement ELISA validation”
    Ensure these keywords appear in title tags, sub‐headings, alt text for visuals (if you include standard curves or assay diagrams), meta-description, and internal links on your marketing page.
    Also integrate external links (as below) to credible educational/government sites to strengthen authority and SEO.

Selected Hyperlinks to .edu/.gov Domains

  1. National Institutes of Health: Physiology of vWF – NCBI Bookshelf. (https://www.ncbi.nlm.nih.gov/books/NBK559062/) ncbi.nlm.nih.gov

  2. Centers for Disease Control and Prevention (CDC): About von Willebrand Disease. (https://www.cdc.gov/von-willebrand/about/index.html) cdc.gov

  3. CDC: Data and Statistics on von Willebrand Disease. (https://www.cdc.gov/von-willebrand/data/index.html) cdc.gov

  4. National Heart, Lung, and Blood Institute (NHLBI): The Facts on von Willebrand Disease. (https://www.nhlbi.nih.gov/resources/facts-von-willebrand-disease-fact-sheet) NHLBI, NIH

  5. FDA 510(k) Summary – vWF Activity Test Kit. (https://www.accessdata.fda.gov/cdrh_docs/reviews/K032139.pdf) accessdata.fda.gov

  6. FDA Device – REAADS vWF ELISA Kit 510(k). (https://www.accessdata.fda.gov/cdrh_docs/pdf/K972005.pdf) accessdata.fda.gov

  7. NCBI PMC: Role of vWF in hemostasis. (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3159913/) pmc.ncbi.nlm.nih.gov

  8. NCBI PMC: Validation of vWF antigen ELISA. (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2568046/) pmc.ncbi.nlm.nih.gov

  9. Practical Haemostasis: vWF Immunological Assays. (https://www.practical-haemostasis.com/Factor%20Assays/vwf/vwf_immunological_assays.html) [Note: not .edu/.gov but technical resource] practical-haemostasis.com

  10. StatPearls – vWF (via NCBI Bookshelf). (https://www.ncbi.nlm.nih.gov/books/NBK565885/) ncbi.nlm.nih.gov

  11. Guidelines: ASH-ISTH-NHF-WFH 2021 on diagnosis of vWD. (https://ashpublications.org/bloodadvances/article/5/1/280/474888/) ashpublications.org

  12. ResearchGate (for reference) – validated rabbit vWF ELISA. (https://www.researchgate.net/publication/49591980_Validated_Sandwich_ELISA_for_the_Quantification_of_von_Willebrand_Factor_in_Rabbit_Plasma) ResearchGate

  13. HHS Public Access (stacks.cdc.gov) – differential diagnosis for hemophilia including vWD. (https://stacks.cdc.gov/view/cdc/32330/DS1.pdf) stacks.cdc.gov

  14. Search for vWF antigen measurement in human plasma (eClinPath). (https://eclinpath.com/hemostasis/tests/von-willebrand-factor/) eClinpath

  15. For further reading: Role of vWF in innate immunity (Nature Communications). (https://www.nature.com/articles/s41467-022-33796-7) Nature
    (You may duplicate some links or expand to 20+ by adding additional .edu/.gov/NIH resources as needed for your page.)

SEO‐Friendly Summary

To summarise in SEO-rich form: “This high-sensitivity sandwich ELISA for von Willebrand factor antigen (vWF:Ag) enables quantitative measurements of vWF in human plasma, supporting endothelial biomarker studies, haemostasis research, and diagnosis of von Willebrand disease (vWD). The assay features a 96-well format, HRP-TMB detection, 4-parameter logistic standard curve, dynamic range from sub-ng/mL to high µg/mL, and validated precision (<10% CV). Compatible with automated plate readers (450 nm), it is ideal for translational labs or contract research organisation (CRO) settings.”

Conclusion

For a company such as yours working in biotechnology reagents, an optimised vWF ELISA kit offers strong market value: bridging research on vascular biology, haemostasis, and translational diagnostics. Emphasise robust validation data, sample flexibility, automation compatibility, and clear documentation. On the marketing side, integrate detailed technical specifications, user-friendly protocols, and reference to the educational/government links above to enhance credibility and search-engine visibility.

If you like, I can draft a full datasheet template (for your “AffiASSAY® vWF ELISA Kit”) including headings, bullet-lists, tables (sensitivity, precision, linear range, sample volume, storage, wash steps), meta-tags and CSS styling in your brand palette. Would you like me to prepare that?